Literature DB >> 26697200

Tumor evolution and intratumor heterogeneity in colorectal carcinoma: insights from comparative genomic profiling of primary tumors and matched metastases.

Brooke E Sylvester1, Efsevia Vakiani1.   

Abstract

Metastatic colorectal cancer (CRC) is one of the leading causes of cancer-related mortality among men and women worldwide. Over the past few decades, advances in our understanding of the genetic and epigenetic underpinnings of CRC have led to important insights into the pathogenesis of invasive tumors and have identified different molecular subgroups. Nonetheless, the events that might facilitate dissemination of tumor cells to distant sites giving rise to metastatic disease are not well characterized. Furthermore, in contrast to intertumor heterogeneity the extent of intratumor heterogeneity in different types of CRC has not been fully defined. In this paper, we review studies that have compared the genetic profile of primary invasive carcinomas to that of matched metastases and discuss the implications of their findings for our understanding of tumor evolution and for the clinical management of patients with advanced CRC.

Entities:  

Keywords:  Colorectal carcinoma; intratumor heterogeneity; tumor evolution

Year:  2015        PMID: 26697200      PMCID: PMC4671856          DOI: 10.3978/j.issn.2078-6891.2015.083

Source DB:  PubMed          Journal:  J Gastrointest Oncol        ISSN: 2078-6891


  38 in total

1.  KRAS and BRAF oncogenic mutations in MSS colorectal carcinoma progression.

Authors:  C Oliveira; S Velho; C Moutinho; A Ferreira; A Preto; E Domingo; A F Capelinha; A Duval; R Hamelin; J C Machado; S Schwartz; F Carneiro; R Seruca
Journal:  Oncogene       Date:  2006-09-04       Impact factor: 9.867

2.  Integrated analysis of genome-wide copy number alterations and gene expression in microsatellite stable, CpG island methylator phenotype-negative colon cancer.

Authors:  Lenora W M Loo; Maarit Tiirikainen; Iona Cheng; Annette Lum-Jones; Ann Seifried; James M Church; Robert Gryfe; Daniel J Weisenberger; Noralane M Lindor; Steven Gallinger; Robert W Haile; David J Duggan; Stephen N Thibodeau; Graham Casey; Loïc Le Marchand
Journal:  Genes Chromosomes Cancer       Date:  2013-01-23       Impact factor: 5.006

3.  Colorectal cancer statistics, 2014.

Authors:  Rebecca Siegel; Carol Desantis; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2014-03-17       Impact factor: 508.702

4.  Genetic changes and clonality relationship between primary colorectal cancers and their pulmonary metastases--an analysis by comparative genomic hybridization.

Authors:  Jeng-Kai Jiang; Yann-Jang Chen; Chi-Hung Lin; I-Ting Yu; Jen-Kou Lin
Journal:  Genes Chromosomes Cancer       Date:  2005-05       Impact factor: 5.006

5.  Chromosome arm 20q gains and other genomic alterations in colorectal cancer metastatic to liver, as analyzed by comparative genomic hybridization and fluorescence in situ hybridization.

Authors:  W M Korn; T Yasutake; W L Kuo; R S Warren; C Collins; M Tomita; J Gray; F M Waldman
Journal:  Genes Chromosomes Cancer       Date:  1999-06       Impact factor: 5.006

Review 6.  Genetics of colorectal cancer.

Authors:  E P Kennedy; S R Hamilton
Journal:  Semin Surg Oncol       Date:  1998-09

7.  Hotspot mutation panel testing reveals clonal evolution in a study of 265 paired primary and metastatic tumors.

Authors:  Rashmi S Goswami; Keyur P Patel; Rajesh R Singh; Funda Meric-Bernstam; E Scott Kopetz; Vivek Subbiah; Ricardo H Alvarez; Michael A Davies; Kausar J Jabbar; Sinchita Roy-Chowdhuri; Alexander J Lazar; L Jeffrey Medeiros; Russell R Broaddus; Rajyalakshmi Luthra; Mark J Routbort
Journal:  Clin Cancer Res       Date:  2015-02-18       Impact factor: 12.531

8.  Prediction of colorectal cancer relapse and survival via tissue RNA levels of matrix metalloproteinase-9.

Authors:  Z S Zeng; Y Huang; A M Cohen; J G Guillem
Journal:  J Clin Oncol       Date:  1996-12       Impact factor: 44.544

9.  High concordance of KRAS status between primary colorectal tumors and related metastatic sites: implications for clinical practice.

Authors:  Daniele Santini; Fotios Loupakis; Bruno Vincenzi; Irene Floriani; Irene Stasi; Emanuele Canestrari; Eliana Rulli; Paolo Enrico Maltese; Francesca Andreoni; Gianluca Masi; Francesco Graziano; Giacomo Giulio Baldi; Lisa Salvatore; Antonio Russo; Giuseppe Perrone; Maria Rosa Tommasino; Mauro Magnani; Alfredo Falcone; Giuseppe Tonini; Annamaria Ruzzo
Journal:  Oncologist       Date:  2008-12-04

10.  Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer.

Authors:  Rafael G Amado; Michael Wolf; Marc Peeters; Eric Van Cutsem; Salvatore Siena; Daniel J Freeman; Todd Juan; Robert Sikorski; Sid Suggs; Robert Radinsky; Scott D Patterson; David D Chang
Journal:  J Clin Oncol       Date:  2008-03-03       Impact factor: 44.544

View more
  9 in total

1.  Mutational landscape of paired primary and synchronous metastatic lymph node in chemotherapy naive gallbladder cancer.

Authors:  Boqiang Fan; Xianfeng Xu; Xuehao Wang
Journal:  Mol Biol Rep       Date:  2022-01-05       Impact factor: 2.316

2.  Contrast-enhanced ultrasound-based ultrasomics score: a potential biomarker for predicting early recurrence of hepatocellular carcinoma after resection or ablation.

Authors:  Hui Huang; Si-Min Ruan; Meng-Fei Xian; Ming-de Li; Mei-Qing Cheng; Wei Li; Yang Huang; Xiao-Yan Xie; Ming-de Lu; Ming Kuang; Wei Wang; Hang-Tong Hu; Li-Da Chen
Journal:  Br J Radiol       Date:  2021-11-29       Impact factor: 3.039

3.  Molecular Heterogeneity of Papillary Thyroid Cancer: Comparison of Primary Tumors and Synchronous Metastases in Regional Lymph Nodes by Mass Spectrometry Imaging.

Authors:  Marta Gawin; Agata Kurczyk; Ewa Stobiecka; Katarzyna Frątczak; Joanna Polańska; Monika Pietrowska; Piotr Widłak
Journal:  Endocr Pathol       Date:  2019-12       Impact factor: 3.943

4.  Intra-patient Inter-metastatic Genetic Heterogeneity in Colorectal Cancer as a Key Determinant of Survival after Curative Liver Resection.

Authors:  Anita Sveen; Inger Marie Løes; Sharmini Alagaratnam; Gro Nilsen; Maren Høland; Ole Christian Lingjærde; Halfdan Sorbye; Kaja Christine Graue Berg; Arild Horn; Jon-Helge Angelsen; Stian Knappskog; Per Eystein Lønning; Ragnhild A Lothe
Journal:  PLoS Genet       Date:  2016-07-29       Impact factor: 5.917

5.  PI3K pathway mutations are associated with longer time to local progression after radioembolization of colorectal liver metastases.

Authors:  Etay Ziv; Michael Bergen; Hooman Yarmohammadi; F Ed Boas; E Nadia Petre; Constantinos T Sofocleous; Rona Yaeger; David B Solit; Stephen B Solomon; Joseph P Erinjeri
Journal:  Oncotarget       Date:  2017-04-04

6.  Chromothripsis and progression-free survival in metastatic colorectal cancer.

Authors:  Elina Skuja; Dagnija Kalniete; Miki Nakazawa-Miklasevica; Zanda Daneberga; Arnis Abolins; Gunta Purkalne; Edvins Miklasevics
Journal:  Mol Clin Oncol       Date:  2017-01-02

7.  Induced Chromosomal Aneuploidy Results in Global and Consistent Deregulation of the Transcriptome of Cancer Cells.

Authors:  Darawalee Wangsa; Rüdiger Braun; Christina H Stuelten; Markus Brown; Kerry M Bauer; Georg Emons; Leigh A Weston; Yue Hu; Howard H Yang; Maria Vila-Casadesús; Maxwell P Lee; Philip Brauer; Lidia Warner; Madhvi Upender; Amanda B Hummon; Jordi Camps; Thomas Ried
Journal:  Neoplasia       Date:  2019-06-04       Impact factor: 5.715

Review 8.  Genetic and epigenetic dependencies in colorectal cancer development.

Authors:  Sehej Parmar; Hariharan Easwaran
Journal:  Gastroenterol Rep (Oxf)       Date:  2022-08-12

Review 9.  Challenges of Neoantigen Targeting in Lynch Syndrome and Constitutional Mismatch Repair Deficiency Syndrome.

Authors:  Asima Abidi; Mark A J Gorris; Evan Brennan; Marjolijn C J Jongmans; Dilys D Weijers; Roland P Kuiper; Richarda M de Voer; Nicoline Hoogerbrugge; Gerty Schreibelt; I Jolanda M de Vries
Journal:  Cancers (Basel)       Date:  2021-05-13       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.